Robert Williamson
Signal active
President and CBO
Bio
Robert Williamson is the President and CBO of Triumvira Immunologics. He previously worked at OncoMyx Therapeutics as a Chief Business and Chief Financial Officer. Robert Williamson attended Stanford University Graduate School of Business.
Location
San Francisco, California, United States, North America
Social
Primary Organization
Triumvira Immunologics
Founded
2015
Employees
51-100
Industry
Biotechnology, Health Care, Clinical Trials
Jobs history
6
Triumvira Immunologics
President and CBO
2022 - Current
Founder
Invalid date - Current
Viron
Chief Business and CFO
2022 - Current
Biotheryx
President & CEO
2020 - 2021
LaSalle Venture Advisers
Owner
2002 - Current
Board Member
2015 - 2020
Board and Advisor Roles
2
SyntheX
Senior Adviser
2022 - Current
Invest in regions
Profile Resume
Robert Williamson is the President and CBO at Triumvira Immunologics, based in United States, North America. With a background in Biotechnology, Robert Williamson has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity